Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Dietary Propolis Ameliorates Dextran Sulfate Sodium-Induced Colitis and Modulates the Gut Microbiota in Rats Fed a Western Diet. β
Go to Publication β
Nutrients (Nutrients ) Vol: 9 Issue 8 Pages: Pub: 2017 Aug 14 Epub: 2017 Aug 14 Authors Wang K , Jin X , You M , Tian W , Le Leu RK , Topping DL , Conlon MA , Wu L , Hu F , |
|
|
Antimicrobial activities of seasonally collected bee products: honey, propolis, royal jelly, venom, and mellitin. β
Go to Publication β
Brazilian journal of biology = Revista brasleira de biologia (Braz J Biol ) Vol: 84 Issue Pages: e286731 Pub: 2024 Epub: 2024 Dec 13 Authors Obeidat M , Haddad MA , Ghnamat SA , |
|
|
Antimicrobial Properties of Acrylic Resin Incorporated with Propolis Nanoparticles. β
Go to Publication β
Frontiers in dentistry (Front Dent ) Vol: 18 Issue Pages: 29 Pub: 2021 Epub: 2021 Jul 26 Authors Arab S , Bahador A , Sodagar A , Pourhajibagher M , Akhavan A , Hafith AN , Pornamazeh T , |
|
|
Antifungal and antibacterial metabolites from a French poplar type propolis. β
Go to Publication β
Evidence-based complementary and alternative medicine : eCAM (Evid Based Complement Alternat Med ) Vol: 2015 Issue Pages: 319240 Pub: 2015 Epub: 2015 Mar 22 Authors Boisard S , Le Ray AM , Landreau A , Kempf M , Cassisa V , Flurin C , Richomme P , |
|
|
In vitro evaluation of Portuguese propolis and floral sources for antiprotozoal, antibacterial and antifungal activity. β
Go to Publication β
Phytotherapy research : PTR (Phytother Res ) Vol: 28 Issue 3 Pages: 437-43 Pub: 2014 Mar Epub: 2013 May 31 Authors Falcão SI , Vale N , Cos P , Gomes P , Freire C , Maes L , Vilas-Boas M , |
|
|
In vitro antimicrobial assessment of Cuban propolis extracts. β
Memorias do Instituto Oswaldo Cruz (Mem Inst Oswaldo Cruz ) Vol: 107 Issue 8 Pages: 978-84 Pub: 2012 Dec Epub: Authors Monzote L , Cuesta-Rubio O , Campo Fernandez M , Márquez Hernandez I , Fraga J , Pérez K , Kerstens M , Maes L , Cos P , |
|
|
Synergistic effects of honey and propolis toward drug multi-resistant Staphylococcus aureus, Escherichia coli and Candida albicans isolates in single and polymicrobial cultures. β
Go to Publication β
International journal of medical sciences (Int J Med Sci ) Vol: 9 Issue 9 Pages: 793-800 Pub: 2012 Epub: 2012 Oct 26 Authors Al-Waili N , Al-Ghamdi A , Ansari MJ , Al-Attal Y , Salom K , |
|
|
Egyptian propolis: 1-antimicrobial activity and chemical composition of Upper Egypt propolis. β
Zeitschrift fur Naturforschung. C, Journal of biosciences (Z Naturforsch C J Biosci ) Vol: 56 Issue 1-2 Pages: 82-8 Pub: 2001 Jan-Feb Epub: Authors Hegazi AG , El Hady FK , |
|
|
Chemical composition and antimicrobial activity of European propolis. β
Zeitschrift fur Naturforschung. C, Journal of biosciences (Z Naturforsch C J Biosci ) Vol: 55 Issue 1-2 Pages: 70-5 Pub: 2000 Jan-Feb Epub: Authors Hegazi AG , Abd El Hady FK , Abd Allah FA , |
|
|
The protective effects of propolis against lipopolysaccharide-induced acute liver injury by modulating serum metabolites and gut flora. β
Go to Publication β
Scientific reports (Sci Rep ) Vol: 15 Issue 1 Pages: 16959 Pub: 2025 May 15 Epub: 2025 May 15 Authors Liu Z , Li Z , Guo Y , Li Y , Xuan H , |
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
